Brought to you by 
UCSD licenses Alzheimer’s diagnostic technology to Cognoptix
10 Dec 2012
Executive Summary
Just one month after changing its name from Neuroptix, Cognoptix Inc. (CNS diagnostic devices) has received an exclusive license to the University of California, San Diego’s technology, which will benefit Cognoptix’s Sapphire II system for early Alzheimer’s detection.
Deal Industry
- Medical Devices
-
Pharmaceuticals
- Radiopharmaceuticals, Contrast Agents
-
Medical Devices
- Diagnostic Equipment & Supplies
- Diagnostic Imaging Equipment & Supplies
- Laser
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
UCSD licenses Alzheimer’s diagnostic technology to Cognoptix
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice